The multifaceted role of Notch in cardiac development and disease

Nature Reviews Genetics

Volumn 9, Issue 1, 2008, Pages 49-61

  High, Frances A ^a   Epstein, Jonathan A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR;

AORTA VALVE DISEASE; ATRIOVENTRICULAR CANAL; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CONGENITAL HEART MALFORMATION; ENDOCARDIAL CUSHION DEFECT; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; HEART; HEART DISEASES; HUMANS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

MUS;

EID: 37449010541     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2279     Document Type: Review

References (108)

1. Bray, S. J. Notch signalling: a simple pathway becomes complex. Nature Rev. Mol. Cell Biol. 7, 678-689 (2006).
2. Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for NOTCH1. Nature Genet. 16, 243-251 (1997).
3. Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature Genet. 16, 235-242 (1997). References 2 and 3 demonstrate that Alagille syndrome is caused by mutations in the human JAG1 gene, providing evidence that mutations in a Notch signalling component could be linked to congenital heart defects.
4. Garg, V. et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270-274 (2005).
5. Joutel, A. et al. NOTCH3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707-710 (1996).
6. Krantz, I. D. et al. JAGGED1 mutations in patients ascertained with isolated congenital heart defects. Am. J. Med. Genet. 84, 56-60 (1999).
7. Eldadah, Z. A. et al. Familial tetralogy of Fallot caused by mutation in the JAGGED1 gene. Hum. Mol. Genet. 10, 163-169 (2001).
8. McDaniell, R. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the Notch signaling pathway. Am. J. Hum. Genet. 79, 169-173 (2006).
9. Li, D. et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Med. Genet. 79, 1030-1039 (2006).
10. Krebs, L. T. et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343-1352 (2000).
11. McCright, B. et al. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 128, 491-502 (2001).
12. Duarte, A. et al. Dosage-sensitive requirement for mouse DLL4 in artery development. Genes Dev. 18, 2474-2478 (2004).
13. Gale, N. W. et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl Acad. Sci. USA 101, 15949-15954 (2004).
14. Krebs, L. T. et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18, 2469-2473 (2004).
15. Xue, Y. et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand JAGGED1. Hum. Mol. Genet. 8, 723-730 (1999).
16. Gridley, T. Notch signaling in vascular development and physiology. Development 134, 2709-2718 (2007).
17. Hofmann, J. J. & Iruela-Arispe, M. L. Notch signaling in blood vessels: who is talking to whom about what? Circ. Res. 100, 1556-1568 (2007).
18. Nemir, M., Croquelois, A., Pedrazzini, T. & Radtke, F. Induction of cardiogenesis in embryonic stem cells via downregulation of NOTCH1 signaling. Circ. Res. 98, 1471-1478 (2006).
19. Schroeder, T. et al. Activated NOTCH1 alters differentiation of embryonic stem cells into mesodermal cell lineages at multiple stages of development. Mech. Dev. 123, 570-579 (2006).
20. Schroeder, T. et al. Recombination signal sequence-binding protein j? alters mesodermal cell fate decisions by suppressing cardiomyogenesis. Proc. Natl Acad. Sci. USA 100, 4018-4023 (2003). This work shows that manipulation of the Notch signalling pathway can be used as a tool to influence cardiac cell-fate specification in cultured ES cells.
21. Park, M., Yaich, L. E. & Bodmer, R. Mesodermal cell fate decisions in Drosophila are under the control of the lineage genes numb, Notch, and sanpodo. Mech. Dev. 75, 117-126 (1998).
22. Rones, M. S., McLaughlin, K. A., Raffin, M. & Mercola, M. Serrate and Notch specify cell fates in the heart field by suppressing cardiomyogenesis. Development 127, 3865-3876 (2000). This study, using X. laevis embryos, was the first to show that Notch inhibits cardiogenesis in a vertebrate model.
23. Han, Z. & Bodmer, R. Myogenic cell fates are antagonized by Notch only in asymmetric lineages of the Drosophila heart, with or without cell division. Development 130, 3039-3051 (2003).
24. Chau, M. D. L., Tuft, R., Fogarty, K. & Bao, Z.-Z. Notch signaling plays a key role in cardiac cell differentiation. Mech. Dev. 123, 626-640 (2006).
25. Watanabe, Y. et al. Activation of NOTCH1 signaling in cardiogenic mesoderm induces abnormal heart morphogenesis in mouse. Development 133, 1625-1634 (2006).
26. Black, B. L. & Olson, E. N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14, 167-196 (1998).
27. Wilson-Rawls, J., Molkentin, J. D., Black, B. L. & Olson, E. N. Activated Notch inhibits myogenic activity of the MADS-box transcription factor myocyte enhancer factor 2C. Mol. Cell. Biol. 19, 2853-2862 (1999).
28. Shen, H. et al. The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev. 675-688 (2006).
29. Habets, P. E. M. H. et al. Cooperative action of TBX2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev. 16, 1234-1246 (2002).
30. Harrelson, Z. et al. TBX2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 131, 5041-5052 (2004).
31. Yamada, M., Revelli, J.-P., Eichele, G., Barron, M. & Schwartz, R. J. Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart development: evidence for BMP2 induction of Tbx-2. Dev. Biol. 228, 95-105 (2000).
32. Kokubo, H., Tomita-Miyagawa, S., Hamada, Y. & Saga, Y. Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development 134, 747-755 (2007).
33. Rutenberg, J. B. et al. Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development 133, 4381-4390 (2006). References 32 and 33 propose a mechanism by which HRT1 and HRT2 create boundaries in the developing AV canal.
34. Eisenberg, L. M. & Markwald, R. R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77, 1-6 (1995).
35. Nieto, M. A. The Snail superfamily of zinc-finger transcription factors. Nature Rev. Mol. Cell Biol. 3, 155-166 (2002).
36. Timmerman, L. A. et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18, 99-115 (2004). Describes the role of Notch in EMT during heart valve development.
37. Noseda, M. et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ. Res. 94, 910-917 (2004).
38. Mohamed, S. A. et al. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem. Biophys. Res. Commun. 345, 1460-1465 (2006).
39. Rajamannan, N. M., Gersh, B. & Bonow, R. O. Calcific aortic stenosis: from bench to the bedside - emerging clinical and cellular concepts. Heart 89, 801-805 (2003).
40. Wang, H. U., Chen, Z.-F. & Anderson, D. J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753 (1998).
41. Lee, K.-F. et al. Requirement for neuregulin receptor ERBB2 in neural and cardiac development. Nature 378, 394-398 (1995).
42. Meyer, D. & Birchmeier, C. Multiple essential functions of neuregulin in development. Nature 378, 386-390 (1995).
43. Gassmann, M. et al. Aberrant neural and cardiac development in mice lacking the ERBB4 neuregulin receptor. Nature 378, 390-394 (1995).
44. Chen, H. et al. BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 131, 2219-2231 (2004).
45. Grego-Bessa, J. et al. Notch signaling is essential for ventricular chamber development. Dev. Cell 12, 415-429 (2007). This paper outlines a genetic pathway by which Notch signalling in the endocardium promotes the differentiation and proliferation of adjacent cardiomyocytes during ventricular chamber development.
46. McElhinney, D. B. et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106, 2567-2574 (2002).
47. McCright, B., Lozier, J. & Gridley, T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129, 1075-1082 (2002).
48. Nakajima, M., Moriizumi, E., Koseki, H. & Shirasawa, T. Presenilin 1 is essential for cardiac morphogenesis. Dev. Dyn. 230, 795-799 (2004).
49. Kopan, R. & Ilagan, M. X. G. γ-secretase: proteasome of the membrane? Nature Rev. Mol. Cell Biol. 5, 499-504 (2004).
50. Stoller, J. Z. & Epstein, J. A. Cardiac neural crest. Semin. Cell Dev. Biol. 16, 704 (2005).
51. Buckingham, M. E., Meilhac, S. & Zaffran, S. Building the mammalian heart from two sources of myocardial cells. Nature Rev. Genet. 6, 826-835 (2005).
52. High, F. A. et al. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J. Clin. Invest. 117, 353-363 (2007). This study demonstrates a requirement for Notch in cardiac neural crest cells during outflow tract development, and describes Notch's role in the differentiation of neural crest cells into vascular smooth muscle.
53. Cornell, R. A. & Eisen, J. S. Notch in the pathway: the roles of Notch signaling in neural crest development. Semin. Cell Dev. Biol. 16, 663-672 (2005).
54. Kamath, B. M. et al. Vascular anomalies in Alagille Syndrome, a significant cause of morbidity and mortality. Circulation 109, 1354-1358 (2004).
55. Doi, H. et al. Jagged1-selective Notch signaling induces smooth muscle differentiation via a RBP-J. κ-dependent pathway. J. Biol. Chem. 281, 28555-28564 (2006).
56. Noseda, M. et al. Smooth muscle ?-actin is a direct target of Notch/CSL. Circ. Res. 98, 1468-1470 (2006).
57. Domenga, V. et al. NOTCH3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 18, 2730-2735 (2004).
58. Doi, H. et al. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler. Thromb. Vasc. Biol. 25, 2328-2334 (2005).
59. Proweller, A., Pear, W. S. & Parmacek, M. S. Notch signaling represses myocardin-induced smooth muscle cell differentiation. J. Biol. Chem. 280, 8994-9004 (2005).
60. Iso, T., Kedes, L. & Hamamori, Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell. Physiol. 194, 237-255 (2003).
61. Iso, T., Chung, G., Hamamori, Y. & Kedes, L. HERP1 is a cell type-specific primary target of Notch. J. Biol. Chem. 277, 6598-6607 (2002).
62. Iso, T. et al. HERP, a new primary target of Notch regulated by ligand binding. Mol. Cell. Biol. 21, 6071-6079 (2001).
63. Nakagawa, O. et al. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc. Natl Acad. Sci. USA 97, 13655-13660 (2000).
64. Chin, M. T. et al. Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. J. Biol. Chem. 275, 6381-6387 (2000).
65. Nakagawa, O., Nakagawa, M., Richardson, J. A., Olson, E. N. & Srivastava, D. HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev. Biol. 216, 72-84 (1999).
66. Kokubo, H., Lun, Y. & Johnson, R. L. Identification and expression of a novel family of bHLH cDNAs related to Drosophila Hairy and Enhancer of Split. Biochem. Biophys. Res. Commun. 260, 459-465 (1999).
67. Leimeister, C., Schumacher, N., Steidl, C. & Gessler, M. Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. Mech. Dev. 98, 175-178 (2000).
68. Leimeister, C., Externbrink, A., Klamt, B. & Gessler, M. Hey genes: a novel subfamily of Hairya- nd Enhancer of split related genes specifically expressed during mouse embryogenesis. Mech. Dev. 85, 173-177 (1999).
69. Sakata, Y. et al. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc. Natl Acad. Sci. USA 99, 16197-16202 (2002).
70. Kokubo, H. et al. Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circ. Res. 95, 540-547 (2004).
71. -/- mice. Curr. Biol. 12, 1601-1604 (2002).
72. Donovan, J., Kordylewska, A., Jan, Y. N. & Utset, M. F. Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice. Curr. Biol. 12, 1605-1610 (2002).
73. -/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mamm. Genome 15, 711-716 (2004).
74. Sakata, Y. et al. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation. J. Mol. Cell. Cardiol. 40, 267-273 (2006).
75. Xin, M. et al. Essential roles of the bHLH transcription factor HRT2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proc. Natl Acad. Sci. USA 104, 7975-7980 (2007).
76. Koibuchi, N. & Chin, M. T. CHF1/HEY2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression. Circ. Res. 100, 850-855 (2007).
77. Fischer, A., Schumacher, N., Maier, M., Sendtner, M. & Gessler, M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901-911 (2004).
78. Kokubo, H., Miyagawa-Tomita, S., Nakazawa, M., Saga, Y. & Johnson, R. L. Mouse Hesr1 and Hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev. Biol. 278, 301-309 (2005).
79. Fischer, A. et al. Combined loss of Hey1 and HeyL Causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ. Res. 100, 856-863 (2007).
80. Fischer, A. et al. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts. Mol. Cell. Biol. 25, 8960-8970 (2005).
81. Kathiriya, I. S. et al. Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism. J. Biol. Chem. 279, 54937-54943 (2004).
82. Xiang, F. et al. Transcription factor CHF1/HEY2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. Am. J. Physiol. Heart Circ. Physiol. 290, H1997-H2006 (2006).
83. Itoh, F. et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 23, 541-551 (2004).
84. Dahlqvist, C. et al. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 130, 6089-6099 (2003).
85. Hurlbut, G. D., Kankel, M. W., Lake, R. J. & Artavanis-Tsakonas, S. Crossing paths with Notch in the hyper-network. Curr. Opin. Cell Biol. 19, 166-175 (2007).
86. Parmacek, M. S. & Epstein, J. A. Pursuing cardiac progenitors: regeneration redux. Cell 120, 295-298 (2005).
87. Chiba, S. Notch signaling in stem cell systems. Stem Cells 24, 2437-2447 (2006).
88. Conboy, I. M. & Rando, T. A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3, 397-409 (2002).
89. Vasyutina, E. et al. RBP-J. (Rbpsuh) is essential to maintain muscle progenitor cells and to generate satellite cells. Proc. Natl Acad. Sci. USA 104, 4443-4448 (2007).
90. Schuster-Gossler, K., Cordes, R. & Gossler, A. Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta1 mutants. Proc. Natl Acad. Sci. USA 104, 537-542 (2007).
91. Luo, D., Renault, V. M. & Rando, T. A. The regulation of Notch signaling in muscle stem cell activation and postnatal myogenesis. Semin. Cell Dev. Biol. 16, 612-622 (2005).
92. Urbanek, K. et al. Stem cell niches in the adult mouse heart. Proc. Natl Acad. Sci. USA 103, 9226-9231 (2006).
93. Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science 298, 2188-2190 (2002).
94. Raya, A. et al. Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc. Natl Acad. Sci. USA 100, 11889-11895 (2003).
95. Lien, C.-L., Schebesta, M., Makino, S., Weber, G. J. & Keating, M. T. Gene expression analysis of zebrafish heart regeneration. PLoS Biol. 4, e260 (2006).
96. Fischer, A. & Gessler, M. Delta-Notch - and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucl. Acids Res. 35, 4583-4596 (2007).
97. Kadesch, T. Notch signaling: the demise of elegant simplicity. Curr. Opin. Genet. Dev. 14, 506-512 (2004).
98. Conlon, R. A., Reaume, A. G. & Rossant, J. NOTCH1 is required for the coordinate segmentation of somites. Development 121, 1533-1545 (1995).
99. Swiatek, P. J., Lindsell, C. E., del Amo, F. F., Weinmaster, G. & Gridley, T. Notch1 is essential for postimplantation development in mice. Genes Dev. 8, 707-719 (1994).
100. Hamada, Y. et al. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development 126, 3415-3424 (1999).
101. Hrabe de Angelis, M., McIntyre, J. & Gossler, A. Maintenance of somite borders in mice requires the Delta homologue Dll1. Nature 386, 717-721 (1997).
102. Dunwoodie, S. L. et al. Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development 129, 1795-1806 (2002).
103. Kusumi, K. et al. The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries. Nature Genet. 19, 274-278 (1998).
104. Jiang, R. et al. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev. 12, 1046-1057 (1998).
105. Oka, C. et al. Disruption of the mouse RBP-J. κ gene results in early embryonic death. Development 121, 3291-3301 (1995).
106. Shen, J. et al. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639 (1997).
107. Donoviel, D. B. et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801-2810 (1999).
108. Herreman, A. et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA 96, 11872-11877 (1999).